Contribution of risk factors to racial/ethnic disparities in tuberculosis among US-born persons
RATIONALE: In the United States, tuberculosis (TB) incidence rates are substantially higher among racial/ethnic minorities compared with non-Hispanic White persons. However, few analyses have investigated the mechanisms driving these disparities. OBJECTIVES: To assess the contribution of geographic factors and individual TB risk factors to racial/ethnic disparities in TB incidence among U.S.-born individuals. METHODS: We analyzed TB case data for 2012-2019 from the National Tuberculosis Surveillance System, stratified by race/ethnicity, age, sex, and Public Use Microdata Area (PUMA). Age-sex standardized incidence rate ratios (IRRs) were calculated to quantify disparities across racial/ethnic groups. We decomposed these IRRs to quantify the contribution of differences within and between PUMAs to overall disparities. We also estimated the contributions of racial/ethnic differences in the prevalence of established TB risk factors-diagnosed diabetes, current smoking, HIV infection, and excess alcohol use-to TB disparities. MEASUREMENTS AND MAIN RESULTS: Non-Hispanic American Indian or Alaska Native and non-Hispanic Native Hawaiian or Pacific Islander persons had the highest TB incidence rates compared to non-Hispanic White persons (IRR: 15.3 (95% CI: 12.5, 18.6) and 18.1 (12.3, 26.2) respectively). Within-PUMA TB incidence differences accounted for most of the differences in incidence by race/ethnicity, representing 52-96% of total IRRs for each racial/ethnic population. Racial/ethnic differences in the prevalence of individual risk factors had minimal impact on total TB incidence disparities. CONCLUSIONS: Eliminating racial/ethnic disparities in TB will require more than addressing individual risk factors. Combatting structural or community-level determinants of TB, including treating infection to prevent disease, will be important for accelerating TB elimination.
Authors
- Andrew N Hill (ORCID: https://orcid.org/0000-0002-7418-6456)
- Awal Khan (ORCID: https://orcid.org/0000-0002-4161-0740)
- Nicole A. Swartwood (ORCID: https://orcid.org/0000-0003-4116-9243)
- Jarvis T. Chen (ORCID: https://orcid.org/0000-0002-7412-1783)
- Joshua A. Salomon (ORCID: https://orcid.org/0000-0003-3929-5515)
- Ted Cohen (ORCID: https://orcid.org/0000-0002-8091-7198)
- Nicolas A. Menzies (ORCID: https://orcid.org/0000-0002-2571-016X)
- Mathilda C. Regan (ORCID: https://orcid.org/0000-0001-6376-3935)
- Yunfei Li (ORCID: https://orcid.org/0000-0002-6891-5392)
- Terrika Barham (ORCID: https://orcid.org/0000-0002-6920-7419)
- Charles Robert Horsburgh (ORCID: https://orcid.org/0000-0001-6838-7895)
Institutions
- Boston University (US)
- Centers for Disease Control and Prevention (US)
- Harvard University (US)
- Yale University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Stanford University (US)
Publication Details
- Journal
- Annals of the American Thoracic Society
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1093/annalsats/aaoag342
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00